Abstract
A total of five patients with respiratory tract infections, one each patient having pneumonia, acute bronchitis, acute tonsillitis and two having pharyngitis, were treated with oral administration of TMS-19-Q·GC at a daily dose of 600mg for five to 23 days. Clinical response was good in three of the patients and fair in the remaining two patients. No adverse symptom and sign was noted during the administration of the drug.
Original language | English |
---|---|
Pages (from-to) | 245-247 |
Number of pages | 3 |
Journal | Chemotherapy |
Volume | 32 |
DOIs | |
Publication status | Published - 1984 Jan 1 |
ASJC Scopus subject areas
- Pharmacology (medical)
- Infectious Diseases
- Pharmacology
- Drug Discovery
- Oncology